KCap Biotechnology Fund LP — Form D
KCap Biotechnology Fund LP of BOSTON, MA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2023-10-11. $1.8M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-10-11
- Form: D
- Accession: 0001995864-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $1.8M
- Investors: 4
- Date of first sale: 2023-10-02
- Security types: fund interests
- SEC file number: 021-494290
Issuer
- Name: KCap Biotechnology Fund LP
- CIK: 0001995864
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 101 HUNTINGTON AVENUE, BOSTON, MA, 02199
- Phone: 617-214-3405
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Douglas Fambrough | Executive Officer | Boston, MA |
| N/A Kuahiwi Capital LLC | Executive Officer | Boston, MA |
Other filings by this issuer (2)
More